TN2010000555A1 - Pharmaceutical dosage form for immediate release of an indolinone derivative - Google Patents

Pharmaceutical dosage form for immediate release of an indolinone derivative

Info

Publication number
TN2010000555A1
TN2010000555A1 TNP2010000555A TN2010000555A TN2010000555A1 TN 2010000555 A1 TN2010000555 A1 TN 2010000555A1 TN P2010000555 A TNP2010000555 A TN P2010000555A TN 2010000555 A TN2010000555 A TN 2010000555A TN 2010000555 A1 TN2010000555 A1 TN 2010000555A1
Authority
TN
Tunisia
Prior art keywords
dosage form
pharmaceutical dosage
immediate release
indolinone derivative
indolinone
Prior art date
Application number
TNP2010000555A
Other languages
French (fr)
Inventor
Roman Messerchmid
Peter Lach
Torsten Sokoliess
Peter Stopfer
Dirk Trommeshauser
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2009/056895 external-priority patent/WO2009147220A1/en
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of TN2010000555A1 publication Critical patent/TN2010000555A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a pharmaceutical dosage form delivering an immediate release profile containing the active substance 3-Z-[l-(4-(N-((4-methyl-piperazin-l-yl)- methylcarbonyl)-N-methyl-amino)-anilino)- 1 -phenyl-methylene] -6-methoxycarbonyl-2- indolinone-monoethanesulphonate.
TNP2010000555A 2009-06-04 2010-12-01 Pharmaceutical dosage form for immediate release of an indolinone derivative TN2010000555A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2009/056895 WO2009147220A1 (en) 2008-06-06 2009-06-04 Pharmaceutical dosage form for immediate release of an indolinone derivative

Publications (1)

Publication Number Publication Date
TN2010000555A1 true TN2010000555A1 (en) 2012-05-24

Family

ID=55024638

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2010000555A TN2010000555A1 (en) 2009-06-04 2010-12-01 Pharmaceutical dosage form for immediate release of an indolinone derivative

Country Status (1)

Country Link
TN (1) TN2010000555A1 (en)

Similar Documents

Publication Publication Date Title
MX338001B (en) Pharmaceutical dosage form for immediate release of an indolinone derivative.
MX359229B (en) Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative.
MX2010005556A (en) Process for the manufacture of an indolinone derivative.
GEP20207129B (en) Inhibitors of influenza viruses replication
EA021377B9 (en) Modulators of toll-like receptors
MY149731A (en) Compounds
TW200616953A (en) Indole, indazole or indoline derivatives
MY156288A (en) Pharmaceutical formulations containing dopamine receptor ligands.
HK1132742A1 (en) Substituted oxindole derivative and its use as a vasopressin receptor modulator
UA98839C2 (en) N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
ECSP11011095A (en) 4- (1,2,3,4-tetrahydroisoquinoline-2-yl) -4-oxobutyric acid amides substituted as modulators of KCNQ2 / 3.
MX2011007267A (en) Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives.
MX2012006022A (en) Novel compounds as receptor modulators with therapeutic utility.
MX2011007451A (en) Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives.
MY157425A (en) Substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
ATE546448T1 (en) UROTENSIN II RECEPTOR ANTAGONISTS
TN2010000555A1 (en) Pharmaceutical dosage form for immediate release of an indolinone derivative
MX2011008126A (en) Substituted indole compounds as bradykinin receptor 1 modulators.
EA201170843A1 (en) PRELIMINARYLY COMPRESSED QUICKLY DECOMPOSING MEDICINAL FORMS OF COMPOUNDS WITH LOW ORAL BIODUSABILITY
TN2010000558A1 (en) Capsule pharmaceutical doage form comprising a suspension formulation of an indolinone derivative
TH115893B (en) Pharmaceutical dosage form, capsule, consisting of an indolinone derivative suspension formulation.
TN2011000018A1 (en) Pharmaceutical formulations containing dopamine receptor ligands
IN2007MU02047A (en)